Emily Elizabeth Bonner DeVille
Plus aucun poste en cours
Profil
Emily Elizabeth Bonner DeVille worked as Vice President of Communications & Training at Pernix Therapeutics, Inc. and Vice President of Sales & Compliance at Pernix Therapeutics Holdings, Inc. She also worked as Manager of Business Development at Praeses Corp.
Bonner DeVille earned an undergraduate degree from Centenary College of Louisiana.
Anciens postes connus de Emily Elizabeth Bonner DeVille
| Sociétés | Poste | Fin |
|---|---|---|
| Pernix Therapeutics, Inc. | Public Communications Contact | - |
| Praeses Corp. | Corporate Officer/Principal | - |
| PERNIX THERAPEUTICS HOLDINGS INC | Compliance Officer | - |
Formation de Emily Elizabeth Bonner DeVille
| Centenary College of Louisiana | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
| Pernix Therapeutics, Inc. | Health Technology |
Pernix Therapeutics Holdings, Inc.
 Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. It distributes products through the following brands: Treximet, Silenor, and Zohydro ER with BeadTek. The company was founded in 1996 and is headquartered in Morristown, NJ. | Health Technology |
| Praeses Corp. |
